What it is
KLOW refers to a multi-peptide research blend typically combining sequences studied individually in skin and matrix research. As a blend it has no regulatory registration and no dedicated clinical evidence base.
The Range
KLOW80 · Pen · Multi-peptide blend research
KLOW 80 mg pen
Research-onlyEvidence: Insufficient
A research blend combining several peptide sequences studied in skin and tissue-matrix contexts. Blends are not registered medicines and have no established clinical evidence base.
Evidence highlights
Mechanism being studied
Any mechanistic discussion derives from the individual constituent peptides studied separately in preclinical settings; combined effects are not characterised.
Human evidence
No adequate controlled human evidence exists for this blend.
Information only — availability subject to applicable law, prescription/authorisation, and licensed healthcare/pharmacy channels. Nothing on this page is an offer to sell, and no dosing or self-administration guidance is provided.
South Africa — compliance notice
SAHPRA has publicly warned about unregistered peptide products being marketed to the South African public. In general, products intended to diagnose, treat, or otherwise alter bodily functions require registration or authorisation before they may lawfully be sold. ELLIVON BIOSCIENCES publishes reference information only and directs all clinical questions to registered healthcare professionals and licensed pharmacy channels.